Fetuin-A Inhibits Placental Cell Growth and Ciliogenesis in Gestational Diabetes Mellitus.
Chia-Yih WangMei-Tsz SuHui-Ling ChengPao-Lin KuoPei-Yin TsaiPublished in: International journal of molecular sciences (2019)
Gestational diabetes mellitus (GDM) is a type of unbalanced glucose tolerance that occurs during pregnancy, which affects approximately 10% of pregnancies worldwide. Fetuin-A is associated with insulin resistance, and the concentration of circulating fetuin-A increases in women with GDM, however, the role of fetuin-A in the placenta remains unclear. In this study, we enrolled placental samples from twenty pregnant women with GDM and twenty non-GDM pregnant women and found that the abundance of fetuin-A was upregulated in terms of mRNA and protein levels. Fetuin-A inhibited placental cell growth by inducing apoptosis and inhibiting S phase entry. Irregular alignment of mitotic chromosomes and aberrant mitotic spindle poles were observed. In addition, centrosome amplification was induced by fetuin-A treatment, and these amplified centrosomes nucleated microtubules with disorganized microtubule arrays in placental cells. Furthermore, fetuin-A inhibited autophagy, and thus blocked the growth of the primary cilium, a cellular antenna that regulates placenta development and differentiation. Thus, our study uncovered the novel function of fetuin-A in regulating placental cell growth and ciliogenesis.
Keyphrases
- pregnant women
- insulin resistance
- endoplasmic reticulum stress
- cell cycle arrest
- signaling pathway
- cell death
- type diabetes
- induced apoptosis
- cell cycle
- adipose tissue
- pregnancy outcomes
- small molecule
- cord blood
- polycystic ovary syndrome
- preterm birth
- weight loss
- combination therapy
- replacement therapy
- high density
- glycemic control